Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

Pennington, B; Alshreef, A; Flight, L; Metry, A; Poku, E; Hykin, P; Sivaprasad, S; Prevost, AT; Vasconcelos, JC; Murphy, C; Kelly, J; Yang, Y; Lotery, A; Williams, M; Brazier, J

Pennington, B (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.

PHARMACOECONOMICS, 2021; 39 (8): 913

Abstract

Background We aimed to assess the cost effectiveness of intravitreal ranibizumab (Lucentis), aflibercept (Eylea) and bevacizumab (Avastin) for the tre......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索